Government set to invest £146m in UK Life Sciences industry
At the launch of his independent review of the Life Sciences industry today, British-Canadian geneticist Sir John Bell announces details of a £146m Government investment in the industry.
The review sets out proposals to encourage growth and investment as a route to tackle concerns about the consequences of Brexit on scientific research, academia, and the pharmaceutical industry.
Launching his report at the University of Birmingham, Sir John says: “We have created a strategy which capitalises on our strong science base to further build the industry into a globally-unique and internationally competitive Life Sciences eco-system, supported by collaboration between industry, Government, the NHS, academia, and research funders to deliver health and wealth.”
The report calls for increased funding for basic science; improving growth and infrastructure; encouraging NHS collaboration through early access to new drugs and adopting a plan to invest in skills across the NHS and Life Sciences.
The Life Sciences sector is of critical importance to the UK economy and UK health – with over 5,000 companies, nearly 235,000 employees and a turnover of £64bn in 2016.
This investment helps to create more UK Life Sciences jobs and ensure the future role of the UK at the heart of this important research and development sector on the global stage. To find out more follow this link…